Furthermore, the bone microenvironment can promote tumor cell survival and proliferation through various signaling pathways, such as the TGF-β pathway, which has been implicated in the progression of bone metastases and the development of resistance to immunotherapy (summarized in Pagnotti et al. [77]). Here, TGFB1 is linked to neoplasm.